Skip to main content
. 2020 Jul 17;3(7):e2010700. doi: 10.1001/jamanetworkopen.2020.10700

Table 3. Duration of Antibiotics Relative to Clinical Signs.

Variable Pneumonia
Community-acquired (n = 9540) Hospital-acquired (n = 2733)
Total duration of treatment, d
All patients
Mean (SD) 5.6 (5.6) 6.8 (7.2)
Median (IQR) 5 (2-7) 5 (3-8)
Patients with normal signs on 1st day of antibiotics
Mean (SD) 4.6 (5.8) 5.5 (5.9)
Median (IQR) 3 (1-6) 5 (2-7)
Patients with abnormal signs on 1st day of antibiotics
Mean (SD) 5.8 (5.5) 7.0 (7.3)
Median (IQR) 5 (2-7) 6 (3-8)
Duration of treatment beyond the last day of abnormal signs
All patients
Mean (SD) 2.5 (4.5) 3.2 (6.2)
Median (IQR) 1 (0-4) 1 (0-5)
Patients with abnormal signs on day 1 of antibiotics
Mean (SD) 2.3 (4.3) 2.4 (5.7)
Median (IQR) 0 (0-4) 0 (0-4)
Patients with extended courses of antibiotics, No. (%)
Antibiotics beyond the last day of abnormal signs
≥3 d 3322 (34.8) 1050 (38.4)
≥5 d 1887 (19.8) 708 (25.9)

Abbreviation: IQR, interquartile range.